Literature DB >> 28479600

A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma.

Huafeng Liu1, Xin Li1, Li Hu1, Min Zhu1, Bailin He1, Liqun Luo1, Lieping Chen2,3.   

Abstract

Programmed death one homolog (PD-1H) is a cell surface molecule of the B7/CD28 immune modulatory gene family. Although PD-1H has been shown to function as a coinhibitory receptor on T cells to limit naive T-cell activation and proliferation, its role in the regulation of the T-cell response to allergens is unknown. We report here that genetic ablation or blockade of PD-1H drastically promotes pulmonary inflammation with massive accumulation of eosinophils in a mouse model of experimental asthma, indicating a suppressive function of PD-1H in allergic inflammation. The loss of PD-1H led to elevated production of both innate cytokines (IL-6, MCP-1 and TNFα) and Th2 cytokines (IL-5 and IL-13) in the lung, indicating a critical role of PD-1H in suppressing the production of airway inflammatory cytokines. In addition, the loss of PD-1H also impaired the expansion of systemic and pulmonary regulatory T cells during asthma induction. These findings support a critical role of intrinsic PD-1H in the regulation of inflammatory responses to allergens. Finally, we showed that treatment with a PD-1H agonistic monoclonal antibody reduced the severity of asthma, which was accompanied by suppressed lung inflammation. Our findings support PD-1H as a potential target and suggest a possible strategy for the treatment of allergic asthma in humans.

Entities:  

Keywords:  Asthma; PD-1H; Th2; VISTA

Mesh:

Substances:

Year:  2017        PMID: 28479600      PMCID: PMC6203798          DOI: 10.1038/cmi.2017.16

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  23 in total

1.  Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models.

Authors:  Dallas B Flies; Shengdian Wang; Haiying Xu; Lieping Chen
Journal:  J Immunol       Date:  2011-07-18       Impact factor: 5.422

Review 2.  Role of Treg in immune regulation of allergic diseases.

Authors:  Oscar Palomares; Görkem Yaman; Ahmet K Azkur; Tunc Akkoc; Mübeccel Akdis; Cezmi A Akdis
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

Review 3.  Early activation defects in T lymphocytes from aged mice.

Authors:  R A Miller; G Garcia; C J Kirk; J M Witkowski
Journal:  Immunol Rev       Date:  1997-12       Impact factor: 12.988

4.  VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis.

Authors:  Sabrina Ceeraz; Petra A Sergent; Sean F Plummer; Alan R Schned; Dov Pechenick; Christopher M Burns; Randolph J Noelle
Journal:  Arthritis Rheumatol       Date:  2017-04       Impact factor: 10.995

5.  Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.

Authors:  Li Wang; Isabelle Le Mercier; Juan Putra; Wenna Chen; Jun Liu; Austin D Schenk; Elizabeth C Nowak; Arief A Suriawinata; Jiannan Li; Randolph J Noelle
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

6.  Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens.

Authors:  Dallas B Flies; Tomoe Higuchi; Lieping Chen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

7.  Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.

Authors:  Kouetsu Ogasawara; Steven K Yoshinaga; Lewis L Lanier
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

Authors:  J X Lin; T S Migone; M Tsang; M Friedmann; J A Weatherbee; L Zhou; A Yamauchi; E T Bloom; J Mietz; S John
Journal:  Immunity       Date:  1995-04       Impact factor: 31.745

Review 9.  Acute graft-versus-host disease: new treatment strategies.

Authors:  Sophie Paczesny; Sung W Choi; James L M Ferrara
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

Review 10.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

View more
  15 in total

Review 1.  VISTA: Coming of age as a multi-lineage immune checkpoint.

Authors:  M A ElTanbouly; E Schaafsma; R J Noelle; J L Lines
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

Review 2.  VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.

Authors:  Mohamed A ElTanbouly; Walburga Croteau; Randolph J Noelle; J Louise Lines
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

3.  Structural insight into T cell coinhibition by PD-1H (VISTA).

Authors:  Benjamin T Slater; Xue Han; Lieping Chen; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-09       Impact factor: 11.205

Review 4.  The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.

Authors:  Wenwen Xu; TạMinh Hiếu; Subramaniam Malarkannan; Li Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

5.  VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.

Authors:  Malte Borggrewe; Susanne M Kooistra; Evelyn M Wesseling; Fenja L Gierschek; Maaike L Brummer; Elizabeth C Nowak; Tiago Medeiros-Furquim; Tegan A Otto; Sam W Lee; Randolph J Noelle; Bart J L Eggen; Jon D Laman
Journal:  Acta Neuropathol Commun       Date:  2021-05-18       Impact factor: 7.801

6.  Activation of TLR Signaling in Sensitization-Recruited Inflammatory Monocytes Attenuates OVA-Induced Allergic Asthma.

Authors:  Chao Huang; Jian Wang; Xiaodong Zheng; Yongyan Chen; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Front Immunol       Date:  2018-11-19       Impact factor: 7.561

7.  VISTA: A Target to Manage the Innate Cytokine Storm.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Evelien Schaafsma; Christopher M Burns; Rodwell Mabaera; Chao Cheng; Randolph J Noelle
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

Review 8.  The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.

Authors:  Negar Hosseinkhani; Afshin Derakhshani; Mahdi Abdoli Shadbad; Antonella Argentiero; Vito Racanelli; Tohid Kazemi; Ahad Mokhtarzadeh; Oronzo Brunetti; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 9.  Exploring the VISTA of microglia: immune checkpoints in CNS inflammation.

Authors:  Malte Borggrewe; Susanne M Kooistra; Randolph J Noelle; Bart J L Eggen; Jon D Laman
Journal:  J Mol Med (Berl)       Date:  2020-08-27       Impact factor: 4.599

10.  VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways.

Authors:  Mohamed A ElTanbouly; Evelien Schaafsma; Nicole C Smits; Parth Shah; Chao Cheng; Christopher Burns; Bruce R Blazar; Randolph J Noelle; Rodwell Mabaera
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.